SCHEMBL26373335

SCHEMBL26373335

c1ccc(-c2ccc(N(c3ccc(-c4ccccc4)cc3)c3ccc(-c4cccc5c4oc4ccccc45)c4oc5c6ccccc6ccc5c34)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.39
▸ ARSA P15289 1/20 0.36
▸ CDC25A P30304 1/20 0.36
▸ CDC25C P30307 1/20 0.36
▸ CYP1A1 P04798 9/20 0.34
▸ CYP1A2 P05177 9/20 0.34
▸ CYP1B1 Q16678 9/20 0.34
▸ PRKDC P78527 5/20 0.34
▸ ABCG2 Q9UNQ0 3/20 0.34
▸ ABCC1 P33527 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ PDE5A O76074 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ ABCB1 P08183 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ CYP19A1 P11511 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26352556 0.97 ALOX5 (0.40) ALOX5ARSACDC25ACDC25CCYP1A1
SCHEMBL27050006 0.95 ALOX5 (0.38) ALOX5ARSACDC25ACDC25CCYP1A1
SCHEMBL27050008 0.95 ALOX5 (0.38) ALOX5ARSACDC25ACDC25CCYP1A1
SCHEMBL27049167 0.91 ALOX5 (0.39) ALOX5ARSACDC25ACDC25CCYP1A1
SCHEMBL24887939 0.90 ALOX5 (0.42) ALOX5ARSACDC25ACDC25CCYP1A1
SCHEMBL26488617 0.90 ALOX5 (0.42) ALOX5ARSACDC25ACDC25CCYP1A1
SCHEMBL26360736 0.90 CYP1A1 (0.38) ARSACDC25ACDC25CCYP1A1CYP1A2
SCHEMBL27051006 0.90 CYP1A1 (0.38) ARSACDC25ACDC25CCYP1A1CYP1A2
SCHEMBL27050001 0.90 ALOX5 (0.35) ALOX5ARSACDC25ACDC25CCYP1A1
SCHEMBL27049134 0.90 ALOX5 (0.35) ALOX5ARSACDC25ACDC25CCYP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240025872-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2024-01-25 — — US disclosed
US-20240025872-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2024-01-25 — — US disclosed
EP-4249478-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT Materials Co., Ltd. (KR) 2023-09-27 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240025872-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1B1, CYP1A1 ALOX5 381/4885ARSA 1596/4885CDC25A 1959/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback